|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Components of Revenue: | |||||
| Total revenues | |||||
| Revenue, net | |||||
| Costs and Expenses: | |||||
| Cost of revenues | |||||
| Selling, general and administrative expenses | |||||
| Impairment charges | |||||
| Product development and research expenses | |||||
| Total costs and expenses | |||||
| Operating loss | |||||
| Other Income (Expense): | |||||
| Other income | |||||
| Foreign currency exchange gain/(loss) | |||||
| Debt partial extinguishment of 2019 Notes | |||||
| Interest and other expense, net | |||||
| Gain/(loss) on debt restructuring | |||||
| Inducement loss | |||||
| Change in the fair value of derivative liabilities | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss attributable to common stockholders | |||||
| Basic and diluted loss per share (in dollars per share) | |||||
| Weighted average shares of common stock outstanding: | |||||
| Basic and diluted (in shares) | |||||
Loading...